Skip to main content

Chlorpheniramine / dextromethorphan / methscopolamine Pregnancy and Breastfeeding Warnings

Brand names: Extendryl DM

Chlorpheniramine / dextromethorphan / methscopolamine Pregnancy Warnings

Chlorpheniramine/DM/methscopolamine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/dextromethorphan/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Chlorpheniramine / dextromethorphan / methscopolamine Breastfeeding Warnings

There are no data on the excretion of chlorpheniramine/DM/methscopolamine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Does Chlorpheniramine/dextromethorphan/methscopolamine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

References for pregnancy information

  1. (2022) "Product Information. Extendryl DM (chlorpheniramine/DM/methscopolamine)." Apothecon Inc

References for breastfeeding information

  1. (2022) "Product Information. Extendryl DM (chlorpheniramine/DM/methscopolamine)." Apothecon Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.